| Total | SHR1 | |||
---|---|---|---|---|---|
Q1 (n = 411) | Q2 (n = 409) | Q3 (n = 412) | Q4 (n = 411) | ||
Ischemia time, hours | 6.13 (4.00, 10.78) | 7.00 (4.23, 11.00) | 6.57 (4.00, 11.00) | 6.00 (4.00, 10.04) | 6.00 (3.84, 10.12) |
Age, years | 62.46 ± 12.58 | 65.14 ± 12.39 | 61.59 ± 12.71 | 60.64 ± 12.59 | 62.46 ± 12.24 |
Sex, male, n (%) | 1323 (80.52) | 325 (79.08) | 335 (81.91) | 349 (84.71) | 314 (76.40) |
Smoking history, n (%) | |||||
 Current | 787 (47.90) | 179 (43.55) | 209 (51.10) | 222 (53.88) | 177 (43.07) |
 Past | 128 (7.79) | 31 (7.54) | 27 (6.60) | 33 (8.01) | 37 (9.00) |
Medical history, n (%) | |||||
 Hypertension | 928 (56.48) | 228 (55.47) | 211 (51.59) | 233 (56.55) | 256 (62.29) |
 Diabetes | 556 (33.84) | 130 (31.63) | 106 (25.92) | 115 (27.91) | 205 (49.88) |
 Hypercholesteremia | 386 (23.49) | 72 (17.52) | 88 (21.52) | 111 (26.94) | 115 (27.98) |
 ASCVD | 231 (14.06) | 71 (17.27) | 52 (12.71) | 47 (11.41) | 61 (14.84) |
Laboratory examinations | |||||
 eGFR, ml/min/1.73m2 | 95.68 ± 18.14 | 92.99 ± 18.02 | 97.26 ± 17.44 | 96.89 ± 16.04 | 95.58 ± 20.53 |
 FBG, mmol/L | 7.01 ± 3.05 | 5.34 ± 1.51 | 5.97 ± 1.50 | 6.76 ± 1.92 | 9.94 ± 4.06 |
 HbA1c, % | 6.58 ± 1.54 | 6.56 ± 1.54 | 6.30 ± 1.22 | 6.43 ± 1.38 | 7.04 ± 1.85 |
 GA, % | 16.10 ± 4.43 | 17.08 ± 4.77 | 15.52 ± 3.78 | 15.37 ± 4.35 | 16.42 ± 4.55 |
 Triglycerides, μmol/L | 1.38 (1.02, 2.04) | 1.27 (0.95, 1.76) | 1.40 (1.06, 2.01) | 1.42 (1.01, 2.07) | 1.52 (1.06, 2.25) |
HDL, μmol/L | 1.05 ± 0.25 | 1.06 ± 0.26 | 1.05 ± 0.27 | 1.04 ± 0.23 | 1.05 ± 0.26 |
LDL, μmol/L | 2.76 ± 0.95 | 2.57 ± 0.92 | 2.82 ± 0.92 | 2.80 ± 0.84 | 2.85 ± 1.08 |
LVEF, % | 51.45 ± 16.14 | 52.69 ± 16.83 | 52.95 ± 15.36 | 51.65 ± 16.36 | 48.48 ± 15.61 |
Procedural information | |||||
Culprit vessel, n (%) | |||||
 LM | 18 (1.10) | 4 (0.97) | 1 (0.24) | 2 (0.49) | 11 (2.68) |
 LAD | 885 (53.86) | 223 (54.26) | 209 (51.10) | 222 (53.88) | 231 (56.20) |
 LCX | 177 (10.77) | 47 (11.44) | 58 (14.18) | 38 (9.22) | 34 (8.27) |
 RCA | 563 (34.27) | 137 (33.33) | 141 (34.47) | 150 (36.41) | 135 (32.85) |
Multivessel disease, n (%) | |||||
 Two-vessel | 407 (24.77) | 114 (27.74) | 92 (22.49) | 102 (24.76) | 99 (24.09) |
 Three-vessel | 263 (16.01) | 60 (14.60) | 66 (16.14) | 63 (15.29) | 74 (18.00) |
TIMI flow, n (%) | |||||
 0 | 665 (40.47) | 123 (29.93) | 154 (37.65) | 193 (46.84) | 195 (47.45) |
 1 | 43 (2.62) | 9 (2.19) | 12 (2.93) | 11 (2.67) | 11 (2.68) |
 2 | 86 (5.23) | 25 (6.08) | 18 (4.40) | 22 (5.34) | 21 (5.11) |
 3 | 849 (51.67) | 254 (61.80) | 225 (55.01) | 186 (45.15) | 184 (44.77) |
Thrombectomy, n (%) | 774 (47.17) | 136 (33.17) | 182 (44.61) | 230 (55.83) | 226 (54.99) |
Number of stents | 1.47 ± 0.80 | 1.54 ± 0.92 | 1.47 ± 0.79 | 1.52 ± 0.80 | 1.37 ± 0.67 |
Diameter of stents | 3.00 (2.75, 3.50) | 3.00 (2.50, 3.50) | 3.00 (2.75, 3.50) | 3.00 (2.75, 3.50) | 3.00 (2.75, 3.50) |
Length of stents | 31.50 (24.00, 46.00) | 32.00 (23.00, 45.25) | 32.00 (23.00, 48.00) | 32.00 (24.00, 50.00) | 30.00 (24.00, 40.00) |
Medication, n (%) | |||||
 Statins | 1598 (97.26) | 406 (98.78) | 403 (98.53) | 404 (98.06) | 385 (93.67) |
 ACEI or ARB | 1302 (79.25) | 318 (77.37) | 338 (82.64) | 330 (80.10) | 316 (76.89) |
 β-Blocker | 1506 (91.66) | 375 (91.24) | 382 (93.40) | 377 (91.50) | 372 (90.51) |